安基林在体设计中重复蛋白质,这些蛋白质与胰岛素样生长因子1型受体结合
José Daniel Mahecha-Ortíz1, Sergio Enríquez-Flores2, Ignacio De la Mora De la Mora2
1Semillero y Grupo de Biotecnología y Genética UCMC, Facultad Ciencias de la Salud, Universidad Colegio Mayor de Cundinamarca, Bogotá, Colombia.
人工智能设计了新型安基林,以向胰岛素样生长因子1型受体 (IGF-1R) 用于癌症治疗. 这些工程蛋白显示出能量有利的结合,表明新的抗癌治疗的潜力.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 计算生物学 计算生物学
背景情况:
- 安基林是稳定的蛋白质,调解蛋白质-蛋白质相互作用,在癌症中具有治疗潜力.
- 胰岛素样生长因子1型受体 (IGF-1R) 在各种癌症中过度表达,使其成为关键的治疗标.
- 抑制IGF-1R与其配体IGF1的结合是抗癌药物开发的重点.
研究的目的:
- 使用人工智能设计基于ankyrin的新型抑制剂,针对IGF-1R.
- 预测和分析设计的基林和IGF-1R之间的结合相互作用.
主要方法:
- 设计了包含IGF1识别位点的ankyrin序列.
- 使用AlphaFold生成了分子模型.
- 使用ClusPro和PDBsum服务器评估了绑定亲和关系和相互作用.
- 分子结合试验证实了相互作用.
主要成果:
- 三种基林 (DAN2SON,Loop-DAN2SON,BI-DAN2SON-D1) 被设计为与IGF-1R进行相互作用.
- 所有设计的安基林-IGF-1R复合体都表现出有利的结合能.
- DAN2SON和Loop-DAN2SON通过键和盐桥通过天然配体位点与IGF-1R结合.
结论:
- 人工智能驱动的蛋白质建模可以预测安基林-IGF-1R相互作用.
- 设计的基林显示出作为向癌症IGF-1R的治疗剂的潜力.
- 需要进一步的体外和体内研究来验证这些发现.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:09Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
相关概念视频
Insulin: The Receptor and Signaling Pathways
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
